Nerve Cap Facilitates Management of Symptomatic Neuromas

It was designed to help treat symptomatic neuromas by isolating the nerve stump from surrounding soft tissues, preventing the ingrowth of fibrous tissue into the nerve. The caps transparency allows for efficient stump positioning and early observation of blood clots, while semi-permeable properties help to maintain the influx of nutrients and other factors required for optimal nerve regeneration. The Neurocap is a product of Polyganics (Groningen, The Netherlands), and has been approved by the US Food and Drug Administration (FDA).

“Neuroma-induced neuropathic pain and morbidity can seriously affect the quality of a patient’s daily life,” said Rudy Mareel, CEO of Polyganics. “We offer orthopedic and hand surgeons a valuable new tool that contributes to the clinical management of neuromas and can improve the daily life of patients.”

Symptomatic neuroma can occur following nerve repair and amputation procedures; there is no known solution to prevent or treat neuromas effectively. Current approaches for treating neuromas are based on surgical removal of the neuroma and surrounding scar tissue and subsequent placing of the nerve stump in tissue, subjected to minimal mechanical stimulation.

Related Links:
Polyganics